A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

NCT07107490 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer

Interventions

DRUG: ALPS12
DRUG: obinutuzumab

Sponsor

Chugai Pharmaceutical